ARVN: Arvinas, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 526.10
Enterprise Value ($M) 426.20
Book Value ($M) 561.70
Book Value / Share 8.17
Price / Book 0.94
NCAV ($M) 537.60
NCAV / Share 7.82
Price / NCAV 0.98

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 4.64
Current Ratio 4.64

Balance Sheet (mrq) ($M)
Current Assets 1,067.30
Assets 1,091.40
Liabilities 529.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 263.40
Operating Income -250.20
Net Income -198.90
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -259.30
Cash from Investing 34.70
Cash from Financing 7.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13G/A BlackRock, Inc. 7.90 -16.52
02-14 13G/A Citadel Advisors Llc 5.10
11-14 13G/A Price T Rowe Associates Inc /md/ 5.60 0.48
11-14 13G/A Rtw Investments, Lp 4.10 -33.97
09-10 13G/A Vanguard Group Inc 10.26 45.19

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 687,444 2,978,283 23.08
2025-04-16 715,485 2,646,538 27.03
2025-04-15 447,868 1,927,303 23.24
2025-04-14 554,815 1,891,494 29.33

(click for more detail)

Similar Companies
ANNX – Annexon, Inc. APLS – Apellis Pharmaceuticals, Inc.
ARQT – Arcutis Biotherapeutics, Inc. ARWR – Arrowhead Pharmaceuticals, Inc.
ASMB – Assembly Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io